BLPH
Price:
$0.035
Market Cap:
$428.14K
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; which has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that has completed Phase 2 dose escalation stage for pulmonary hypertension asso...[Read more]
Industry
Biotechnology
IPO Date
2015-02-13
Stock Exchange
NASDAQ
Ticker
BLPH
According to Bellerophon Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.04. This represents a change of -102.71% compared to the average of 1.48 of the last 4 quarters.
The mean historical PE Ratio of Bellerophon Therapeutics, Inc. over the last ten years is -4.52. The current -0.04 PE Ratio has changed -11.60% with respect to the historical average. Over the past ten years (40 quarters), BLPH's PE Ratio was at its highest in in the March 2018 quarter at 7.24. The PE Ratio was at its lowest in in the June 2015 quarter at -33.15.
Average
-4.52
Median
-1.72
Minimum
-28.01
Maximum
18.52
Discovering the peaks and valleys of Bellerophon Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 457.55%
Maximum Annual PE Ratio = 18.52
Minimum Annual Increase = -1110.45%
Minimum Annual PE Ratio = -28.01
Year | PE Ratio | Change |
---|---|---|
2022 | -0.43 | -73.87% |
2021 | -1.66 | -21.11% |
2020 | -2.10 | 18.02% |
2019 | -1.78 | -109.62% |
2018 | 18.52 | -1110.45% |
2017 | -1.83 | 457.55% |
2016 | -0.33 | -57.93% |
2015 | -0.78 | -97.09% |
2014 | -26.84 | -4.16% |
2013 | -28.01 | -25.44% |
The current PE Ratio of Bellerophon Therapeutics, Inc. (BLPH) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.40
5-year avg
2.51
10-year avg
-4.52
Bellerophon Therapeutics, Inc.’s PE Ratio is less than Bio-Path Holdings, Inc. (0), greater than Catalyst Biosciences, Inc. (-0.14), greater than Diffusion Pharmaceuticals Inc. (-0.44), less than Capricor Therapeutics, Inc. (-0.00), greater than NextCure, Inc. (-4.65), greater than Zura Bio Limited (-0.65), greater than Altamira Therapeutics Ltd. (-9.00), less than Immix Biopharma, Inc. (-0.03), greater than Enveric Biosciences, Inc. (-2.98), greater than Palisade Bio, Inc. (-0.36), greater than null (-0.31),
Company | PE Ratio | Market cap |
---|---|---|
0 | $2.51M | |
-0.14 | $19.42M | |
-0.44 | $8.98M | |
-0.00 | $132.76M | |
-4.65 | $39.73M | |
-0.65 | $230.86M | |
-9.00 | $2.04M | |
-0.03 | $54.08M | |
-2.98 | $4.53M | |
-0.36 | $4.25M | |
-0.31 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bellerophon Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bellerophon Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Bellerophon Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Bellerophon Therapeutics, Inc. (BLPH)?
What is the highest PE Ratio for Bellerophon Therapeutics, Inc. (BLPH)?
What is the 3-year average PE Ratio for Bellerophon Therapeutics, Inc. (BLPH)?
What is the 5-year average PE Ratio for Bellerophon Therapeutics, Inc. (BLPH)?
How does the current PE Ratio for Bellerophon Therapeutics, Inc. (BLPH) compare to its historical average?